An imaging-based platform for high-content, quantitative evaluation of therapeutic response in 3D tumour models

被引:110
作者
Celli, Jonathan P. [1 ,2 ,3 ]
Rizvi, Imran [1 ,2 ]
Blanden, Adam R. [1 ,2 ]
Massodi, Iqbal [1 ,2 ]
Glidden, Michael D. [1 ,2 ,3 ]
Pogue, Brian W. [4 ]
Hasan, Tayyaba [1 ,2 ]
机构
[1] Massachusetts Gen Hosp, Wellman Ctr Photomed, Boston, MA 02114 USA
[2] Harvard Univ, Sch Med, Boston, MA USA
[3] Univ Massachusetts, Dept Phys, Boston, MA 02125 USA
[4] Dartmouth Coll, Thayer Sch Engn, Hanover, NH 03755 USA
来源
SCIENTIFIC REPORTS | 2014年 / 4卷
关键词
EPITHELIAL OVARIAN-CANCER; PHOTODYNAMIC THERAPY; NUCLEAR-ORGANIZATION; TISSUE STRUCTURE; GENE-EXPRESSION; GEMCITABINE; RESISTANCE; TARGET; CARBOPLATIN; APOPTOSIS;
D O I
10.1038/srep03751
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
While it is increasingly recognized that three-dimensional (3D) cell culture models recapitulate drug responses of human cancers with more fidelity than monolayer cultures, a lack of quantitative analysis methods limit their implementation for reliable and routine assessment of emerging therapies. Here, we introduce an approach based on computational analysis of fluorescence image data to provide high-content readouts of dose-dependent cytotoxicity, growth inhibition, treatment-induced architectural changes and size-dependent response in 3D tumour models. We demonstrate this approach in adherent 3D ovarian and pancreatic multiwell extracellular matrix tumour overlays subjected to a panel of clinically relevant cytotoxic modalities and appropriately designed controls for reliable quantification of fluorescence signal. This streamlined methodology reads out the high density of information embedded in 3D culture systems, while maintaining a level of speed and efficiency traditionally achieved with global colorimetric reporters in order to facilitate broader implementation of 3D tumour models in therapeutic screening.
引用
收藏
页数:10
相关论文
共 47 条
[1]   Prognostic factors of stage IV epithelial ovarian cancer: A multicenter retrospective study [J].
Akahira, JI ;
Yoshikawa, H ;
Shimizu, Y ;
Tsunematsu, R ;
Hirakawa, T ;
Kuramoto, H ;
Shiromizu, K ;
Kuzuya, K ;
Kamura, T ;
Kikuchi, Y ;
Kodama, S ;
Yamamoto, K ;
Sato, S .
GYNECOLOGIC ONCOLOGY, 2001, 81 (03) :398-403
[2]   Determinants of drug delivery and transport to solid tumors [J].
Au, JLS ;
Jang, SH ;
Zheng, J ;
Chen, CT ;
Song, S ;
Hu, L ;
Wientjes, MG .
JOURNAL OF CONTROLLED RELEASE, 2001, 74 (1-3) :31-46
[3]  
Berridge MV, 2005, BIOTECHNOL ANN REV, V11, P127, DOI 10.1016/S1387-2656(05)11004-7
[4]  
Bissell MJ, 1999, CANCER RES, V59, p1763S
[5]   Putting tumours in context [J].
Bissell, MJ ;
Radisky, D .
NATURE REVIEWS CANCER, 2001, 1 (01) :46-54
[6]  
Bissell MJ, 1999, CANCER RES, V59, p1757S
[7]   Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: A randomized trial [J].
Burris, HA ;
Moore, MJ ;
Andersen, J ;
Green, MR ;
Rothenberg, ML ;
Madiano, MR ;
Cripps, MC ;
Portenoy, RK ;
Storniolo, AM ;
Tarassoff, P ;
Nelson, R ;
Dorr, FA ;
Stephens, CD ;
VanHoff, DD .
JOURNAL OF CLINICAL ONCOLOGY, 1997, 15 (06) :2403-2413
[8]   Verteporfin-Based Photodynamic Therapy Overcomes Gemcitabine Insensitivity in a Panel of Pancreatic Cancer Cell Lines [J].
Celli, Jonathan P. ;
Solban, Nicolas ;
Liang, Alvin ;
Pereira, Stephen P. ;
Hasan, Tayyaba .
LASERS IN SURGERY AND MEDICINE, 2011, 43 (07) :565-574
[9]   Quantitative imaging reveals heterogeneous growth dynamics and treatment-dependent residual tumor distributions in a three-dimensional ovarian cancer model [J].
Celli, Jonathan P. ;
Rizvi, Imran ;
Evans, Conor L. ;
Abu-Yousif, Adnan O. ;
Hasan, Tayyaba .
JOURNAL OF BIOMEDICAL OPTICS, 2010, 15 (05)
[10]  
Chen X., MOL CELL BIOL, V30, P3048